Head & Neck Cancer Drugs
SKU
MRR-43676CF4239E
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 1.35 billion
2030
USD 3.70 billion
2024
USD 1.56 billion
CAGR
15.43%

Head & Neck Cancer Drugs Market by Product (Bleomycin, Cetuximab, Docetaxel), Drug Class (Chemotherapy, Immunotherapy, Radiation therapy), End User - Global Forecast 2024-2030

[192 Pages Report] The Head & Neck Cancer Drugs Market size was estimated at USD 1.35 billion in 2023 and expected to reach USD 1.56 billion in 2024, at a CAGR 15.43% to reach USD 3.70 billion by 2030.

Head & Neck Cancer Drugs Market
To learn more about this report, request a free PDF copy
Head & Neck Cancer Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Head & Neck Cancer Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Head & Neck Cancer Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Head & Neck Cancer Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca PLC, BeiGene Ltd., Biocon Limited, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline PLC, Incyte Corporation, Merck & Co., Inc., NEC Corporation, Novartis AG, Pfizer Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Head & Neck Cancer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Bleomycin
    • Cetuximab
    • Docetaxel
    • Erbitux (Cetuximab)
    • Hydrea (Hydroxyurea)
    • Hydroxyurea
    • Keytruda (Pembrolizumab)
    • Methotrexate
    • Nivolumab
    • Opdivo (Nivolumab)
    • Pembrolizumab
    • Taxotere (Docetaxel)
    • Trexall (Methotrexate)
  • Drug Class
    • Chemotherapy
    • Immunotherapy
    • Radiation therapy
    • Surgery
    • Targeted Therapy
  • End User
    • Cancer Research Institutes
    • Clinics
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Head & Neck Cancer Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Head & Neck Cancer Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Head & Neck Cancer Drugs Market?
  4. What is the market share of the leading vendors in the Head & Neck Cancer Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Head & Neck Cancer Drugs Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Rising incidence of head and neck cancer all across the globe
        2. Rise in government and private body initiatives for cancer treatment
        3. Increased approval for head & neck cancer drugs
      2. Restraints
        1. High cost of the drugs
      3. Opportunities
        1. Favorable reimbursements for head and neck cancer drugs
        2. New investments for developing late-stage pipeline drugs
      4. Challenges
        1. Adverse effect associated with the consumption of the drug
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Head & Neck Cancer Drugs Market, by Product
    1. Introduction
    2. Bleomycin
    3. Cetuximab
    4. Docetaxel
    5. Erbitux (Cetuximab)
    6. Hydrea (Hydroxyurea)
    7. Hydroxyurea
    8. Keytruda (Pembrolizumab)
    9. Methotrexate
    10. Nivolumab
    11. Opdivo (Nivolumab)
    12. Pembrolizumab
    13. Taxotere (Docetaxel)
    14. Trexall (Methotrexate)
  7. Head & Neck Cancer Drugs Market, by Drug Class
    1. Introduction
    2. Chemotherapy
    3. Immunotherapy
    4. Radiation therapy
    5. Surgery
    6. Targeted Therapy
  8. Head & Neck Cancer Drugs Market, by End User
    1. Introduction
    2. Cancer Research Institutes
    3. Clinics
    4. Hospitals
  9. Americas Head & Neck Cancer Drugs Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Head & Neck Cancer Drugs Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Head & Neck Cancer Drugs Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. HEAD & NECK CANCER DRUGS MARKET RESEARCH PROCESS
    2. HEAD & NECK CANCER DRUGS MARKET SIZE, 2023 VS 2030
    3. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. HEAD & NECK CANCER DRUGS MARKET DYNAMICS
    7. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    8. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
    10. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
    12. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. HEAD & NECK CANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
    22. HEAD & NECK CANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 310]
    1. HEAD & NECK CANCER DRUGS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    8. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    9. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY BLEOMYCIN, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY BLEOMYCIN, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CETUXIMAB, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CETUXIMAB, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DOCETAXEL, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DOCETAXEL, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY ERBITUX (CETUXIMAB), BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY ERBITUX (CETUXIMAB), BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDREA (HYDROXYUREA), BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDREA (HYDROXYUREA), BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDROXYUREA, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDROXYUREA, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY KEYTRUDA (PEMBROLIZUMAB), BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY KEYTRUDA (PEMBROLIZUMAB), BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY METHOTREXATE, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY NIVOLUMAB, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY NIVOLUMAB, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY OPDIVO (NIVOLUMAB), BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY OPDIVO (NIVOLUMAB), BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PEMBROLIZUMAB, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PEMBROLIZUMAB, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TAXOTERE (DOCETAXEL), BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TAXOTERE (DOCETAXEL), BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TREXALL (METHOTREXATE), BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TREXALL (METHOTREXATE), BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    36. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    37. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
    40. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
    41. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
    43. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
    44. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
    45. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
    46. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
    47. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    48. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    49. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
    50. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
    51. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
    52. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
    53. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
    54. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
    55. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    56. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    57. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    58. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    59. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    60. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    61. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    62. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    63. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    64. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    65. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    66. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    67. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    68. ARGENTINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    69. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    70. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    71. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    72. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    73. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    74. BRAZIL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    75. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    76. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    77. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    78. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    79. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    80. CANADA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    81. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    82. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    83. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    84. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    85. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    86. MEXICO HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    87. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    88. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    89. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    90. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    91. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    92. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    93. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    94. UNITED STATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    95. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    96. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    97. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    98. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    99. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    100. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    101. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    102. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    103. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    104. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    105. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    106. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    107. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    108. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    109. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    110. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    111. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    112. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    113. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    114. CHINA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    115. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    116. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    117. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    118. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    119. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    120. INDIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    121. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    122. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    123. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    124. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    125. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    126. INDONESIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    127. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    128. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    129. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    130. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    131. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    132. JAPAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    133. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    134. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    135. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    136. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    137. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    138. MALAYSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    139. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    140. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    141. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    142. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    143. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    144. PHILIPPINES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    145. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    146. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    147. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    148. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    149. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    150. SINGAPORE HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    151. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    152. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    153. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    154. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    155. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    156. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    157. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    158. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    159. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    160. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    161. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    162. TAIWAN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    163. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    164. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    165. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    166. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    167. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    168. THAILAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    169. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    170. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    171. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    172. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    173. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    174. VIETNAM HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    175. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    176. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    177. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    178. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    179. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    180. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    181. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    182. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    183. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    184. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    185. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    186. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    187. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    188. DENMARK HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    189. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    190. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    191. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    192. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    193. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    194. EGYPT HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    195. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    196. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    197. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    198. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    199. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    200. FINLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    201. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    202. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    203. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    204. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    205. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    206. FRANCE HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    207. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    208. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    209. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    210. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    211. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    212. GERMANY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    213. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    214. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    215. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    216. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    217. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    218. ISRAEL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    219. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    220. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    221. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    222. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    223. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    224. ITALY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    225. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    226. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    227. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    228. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    229. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    230. NETHERLANDS HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    231. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    232. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    233. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    234. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    235. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    236. NIGERIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    237. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    238. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    239. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    240. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    241. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    242. NORWAY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    243. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    244. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    245. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    246. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    247. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    248. POLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    249. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    250. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    251. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    252. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    253. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    254. QATAR HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    255. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    256. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    257. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    258. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    259. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    260. RUSSIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    261. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    262. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    263. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    264. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    265. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    266. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    267. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    268. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    269. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    270. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    271. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    272. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    273. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    274. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    275. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    276. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    277. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    278. SPAIN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    279. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    280. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    281. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    282. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    283. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    284. SWEDEN HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    285. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    286. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    287. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    288. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    289. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    290. SWITZERLAND HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    291. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    292. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    293. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    294. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    295. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    296. TURKEY HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    297. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    298. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    299. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    300. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    301. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    302. UNITED ARAB EMIRATES HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    303. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    304. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    305. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
    306. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
    307. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    308. UNITED KINGDOM HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    309. HEAD & NECK CANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
    310. HEAD & NECK CANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 15]
    1. AbbVie Inc.
    2. Amgen Inc.
    3. AstraZeneca PLC
    4. BeiGene Ltd.
    5. Biocon Limited
    6. Bristol-Myers Squibb Company
    7. F. Hoffmann-La Roche Ltd.
    8. Gilead Sciences, Inc.
    9. GlaxoSmithKline PLC
    10. Incyte Corporation
    11. Merck & Co., Inc.
    12. NEC Corporation
    13. Novartis AG
    14. Pfizer Inc.
    15. Sanofi S.A.
Frequently Asked Questions
  1. How big is the Head & Neck Cancer Drugs Market?
    Ans. The Global Head & Neck Cancer Drugs Market size was estimated at USD 1.35 billion in 2023 and expected to reach USD 1.56 billion in 2024.
  2. What is the Head & Neck Cancer Drugs Market growth?
    Ans. The Global Head & Neck Cancer Drugs Market to grow USD 3.70 billion by 2030, at a CAGR of 15.43%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.